Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lethal "thin" malignant melanoma. Identifying patients at risk.

C L Slingluff1, R T Vollmer, D S Reintgen

  • 1Duke University Medical Center, Durham, NC 27710.

Annals of Surgery
|August 1, 1988
PubMed
Summary

Thin melanomas can spread and be fatal. This study identified male sex, axial primaries, and severe histologic regression as key risk factors for melanoma metastasis, aiding in risk stratification for better treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statistical controversies in clinical research: early-phase adaptive design for combination immunotherapies.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Recent developments in the implementation of novel designs for early-phase combination studies.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

A molecular technique useful in the detection of occult metastases in patients with melanoma : rt-PCR analysis of sentinel lymph nodes and peripheral blood.

Methods in molecular medicine·2012
Same author

Monitoring antitumour immune response during immunotherapy of cancer: why and how?

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Same author

Controversial topics in breast lymphatic mapping.

Seminars in oncology·2004
Same author

Importance of missed axillary micrometastases in breast cancer patients.

The breast journal·2002

Area of Science:

  • Dermatology
  • Oncology
  • Pathology

Background:

  • Thin melanomas (<0.76 mm) can metastasize and be lethal.
  • Accurate risk assessment is crucial for managing thin melanoma patients.

Purpose of the Study:

  • To identify negative prognostic factors for metastasis in thin melanoma patients.
  • To develop a prognostic model for stratifying metastasis risk.

Main Methods:

  • Retrospective review of 681 thin melanoma patients.
  • Analysis of clinical (sex, primary site) and histologic (regression, Clark's Level) factors.
  • Development of a prognostic model incorporating identified risk factors.

Main Results:

  • Male sex and axial primary sites were associated with increased metastasis risk.

Related Experiment Videos

  • Severe histologic regression was a significant predictor of metastasis (p < 0.001).
  • A prognostic model identified low-risk (women, extremity primaries) and high-risk groups with distinct metastasis rates.

    • Conclusions:

    • A prognostic model using clinical and histologic factors can effectively stratify thin melanoma patients by metastasis risk.
    • Identifying high-risk patients may improve adjuvant therapy guidelines.
    • Low-risk populations (e.g., women with extremity primaries) have a very low 10-year metastasis risk (<3%).